Methoxsalen – July 2026

  • Brand names:
    • Uvadex®
  • Pharmaceutical Company:
    • HEALTH TECHNOLOGY ANALYSTS PTY LIMITED
  • Condition/Indication: Cutaneous T-cell lymphoma (CTCL) Chronic graft versus host disease (cGVHD)
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026